Skip to content
★ Sign in to follow
QL

Quest Laboratories Limited Stock: price and insider trades · India

IN·Mcap ₹1.5BHealth Care

No insider purchase over the last 90 days. The latest, by Anil Kumar Sabarwal, was filed 30 Jun 2025.

Quest Laboratories Limited: what insiders have been doing

Quest Laboratories Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). The past year has been quiet: not a single insider filing for Quest Laboratories Limited. The previous disclosure was published on 30 June 2025.

Looking back to 2025, when coverage begins, insiders filed 9 purchases and no sales.

Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Insider Decl.
9
Thresholds
n/a
Buy Volume
€93,106
9 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Anil Kumar Sabarwal4 buys
Vinayak Sabarwal3 buys
Tejaswini Sabarwal2 buys

Since the insiders bought

  • Filed 30 Jun 2025 · 496 days ago
    -1.6%
    Entry ₹95.60 · Close at T+90 ₹94.05
  • Filed 07 Jun 2025 · 519 days ago · €1
    +14.4%
    Entry ₹83.95 · Close at T+90 ₹96.00
  • Filed 03 Jun 2025 · 523 days ago · €1
    +18.1%
    Entry ₹83.85 · Close at T+90 ₹99.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 8,504 of 26,897 companies
60.8
score / 100
Value
58
Quality
64
FCF yld-11%
Earn yld10%
EV/EBITDA7.5x
ROE·
Gross mgn22%
Net mgn13%
Debt/EBITDA0.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹90.20
Income statement
Revenue₹1.1B
Gross profit₹243.4M22% margin
EBITDA₹207.8M19% margin
Net income₹150.2M13.4% margin
Balance sheet & cash
Market cap₹1.5B
Total debt₹78.9M
Free Cash Flow-₹159.7M
Last declaration on 30 June 2025
Declarations9 total
  • ▲
    Executives
    17SEBI
    69,600 shares0.0% of flowEquity SharesSEBI:4303cff6bed2eb3f67c24284145b622c41ef093c
    Canonical exit: 28 Sept 2025 (T+90)
  • ▲
    Executives
    84 INR25SEBI
    4,800 shares@ ₹0.0175100.0% of flowEquity SharesSEBI:3e888eb67c68096ba5d68ebccdae8ab9b67f6a94
    Canonical exit: 4 Sept 2025 (T+90)
  • ▲
    Executives
    14SEBI
    13,200 shares0.0% of flowEquity SharesSEBI:48541026acda16f7220397e02d5c6f982ea4b7b6
    Canonical exit: 31 Aug 2025 (T+90)
  • ▲
    Executives
    89 INR14SEBI
    6,000 shares@ ₹0.01480.0% of flowEquity SharesSEBI:05241857e87563cb80b7936524b215a4d59d695d
    Canonical exit: 31 Aug 2025 (T+90)
  • ▲
    Executives
    310,800 INR19SEBI
    2,400 shares@ ₹129.5019.9% of flowEquity SharesSEBI:6f4407a0e36b36ee7903e47d46f6779b97f021af
    Canonical exit: 16 Apr 2025 (T+90)
  • ▲
    Executives
    1M INR25SEBI
    9,600 shares@ ₹130.2080.1% of flowEquity SharesSEBI:cf6724e9cb9301fa9311619ae7e244a54f594df1
    Canonical exit: 15 Apr 2025 (T+90)
  • ▲
    Executives
    967,320 INR16SEBI
    7,200 shares@ ₹134.3518.8% of flowEquity SharesSEBI:c31892b63ce2b55cbcf576002ec7ec830d31c0ee
    Canonical exit: 10 Apr 2025 (T+90)
  • ▲
    Executives
    2M INR22SEBI
    10,800 shares@ ₹144.2611100.0% of flowEquity SharesSEBI:f85db4b6d3dbb35da63d885a777a4e90bfd7ceb0
    Canonical exit: 9 Apr 2025 (T+90)
  • ▲
    Executives
    4M INR10SEBI
    33,600 shares@ ₹124.889281.2% of flowEquity SharesSEBI:c2793bd928fdb2301daeaaca74cf707658f2ebfa
    Canonical exit: 2 Apr 2025 (T+90)

9 of 9 declarations

About Quest Laboratories Limited

Quest Laboratories Limited is a company operating in the health and pharmaceutical sector. It is listed on the XBOM.